A randomized controlled study on the effectiveness and safety of PPI and H2RA in the prevention of stress ulcers in patients with perioperative general surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039727

Enrollment

Unknown

Registered

2020-11-06

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Ulcer

Interventions

PPI :Use PPI to prevent stress ulcer bleeding

H2RA:Use H2 receptor antagonist to prevent stress ulcer bleeding

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged >= 18 years; 2) Patients who are planning to undergo surgery; 3) Expected hospital stay >= 48h; 4) Sign the informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: 1) Patients during pregnancy and lactation; 2) Severe liver insufficiency (Child-Pugh score C); 3) Other unsuitable cases after clinical evaluation (This need to be approved by at least two project team members, including at least one clinical expert, and record the reasons for exclusion).

Design outcomes

Primary

Measure	Time frame
Clinically significant gastrointestinal bleeding;	—

Secondary

Measure	Time frame
Occult gastrointestinal bleeding;Obvious gastrointestinal bleeding;Postoperative hospital stay;Adverse events;	—

Countries

China

Contacts

Public ContactLi Dandan

Beijing Friendship Hospital, Capital Medical University

vistaldd@sina.com+86 15652974695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026